Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin.

52W Range

1stpctl

Volume

0.16×avg

Market Cap

80070USD

P/E Ratio

-TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Psyence Biomedical Ltd.

PBMNASDAQ Capital Market·USD·Closed

Psyence Biomedical Ltd.

PBMNASDAQ·USD·Closed

$4.21

−2.32%

$4.21

−$0.10 (2.32%)

52W Range

1stpctl

Volume

0.16×avg

Mkt Cap

80070USD

P/E

–TTM

Div Yield

–ann

PBM: Psyence Biomedical Ltd. Stock Analysis | finqOS